Foghorn Therapeutics (FHTX) Amortizatization of Intangibles (2020 - 2026)

Foghorn Therapeutics' (FHTX) quarterly Amortizatization of Intangibles came in at $388000.0 in Q1 2026, down 52.57% year-on-year from $818000.0 in Q1 2025, and up 26.8% quarter-over-quarter from $306000.0 in Q4 2025.

Foghorn Therapeutics (FHTX) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Foghorn Therapeutics' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $388000.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 52.57% year-over-year to $388000.0 in Q1 2026; TTM through Mar 2026 was $1.5 million, a 69.33% decrease from a year earlier, with the FY2025 full-year figure at $1.9 million, down 58.25% from the prior year.
  • Amortizatization of Intangibles rose to $388000.0 in Q1 2026 per FHTX's latest filing, from $306000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.8 million in Q3 2024 and bottomed at -$38000.0 in Q1 2022.
  • The 5-year median for Amortizatization of Intangibles is $554000.0 (2024), against an average of $639588.2.
  • Biggest YoY gain for Amortizatization of Intangibles was 6540.0% in 2022; the steepest drop was 392.31% in 2022.
  • Year by year, Amortizatization of Intangibles stood at $574000.0 in 2022, then slipped by 13.76% to $495000.0 in 2023, then surged by 216.97% to $1.6 million in 2024, then tumbled by 80.5% to $306000.0 in 2025, then increased by 26.8% to $388000.0 in 2026.
  • Per Business Quant, the three latest FHTX Amortizatization of Intangibles figures stand at $388000.0 (Q1 2026), $306000.0 (Q4 2025), and $356000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Foghorn Therapeutics 362.65 Mn 273.74 Mn - 388,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 388,000.00
Mar 31, 2026 388,000.00
Dec 31, 2025 306,000.00
Dec 31, 2025 306,000.00
Sep 30, 2025 356,000.00
Sep 30, 2025 356,000.00
Jun 30, 2025 446,000.00
Jun 30, 2025 446,000.00
Mar 31, 2025 818,000.00
Mar 31, 2025 818,000.00
Dec 31, 2024 1.57 Mn
Dec 31, 2024 1.57 Mn
Sep 30, 2024 1.79 Mn
Sep 30, 2024 1.79 Mn
Jun 30, 2024 705,000.00
Jun 30, 2024 705,000.00
Mar 31, 2024 554,000.00
Mar 31, 2024 554,000.00
Dec 31, 2023 495,000.00
Dec 31, 2023 495,000.00